Pulmozyme DNase: Phase III study to start in the fall

Genentech Inc. (GNE), South San Francisco Product: Pulmozyme DNase Indication: Patients with chronic obstructive pulmonary disease with exacerbations requiring hospitalization Status: Phase III study...